MAG
GHDX

Millrace Asset Group’s Genomic Health, Inc. GHDX Stock Holding History

Millrace Asset Group’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-17,500
Closed -$13K – 80
2018
Q1 		$13K Buy
+17,500
New +$581K 0.01% 64

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Millrace Asset Group's GHDX Position: Q2 2018 in Review

Millrace Asset Group sold out of Genomic Health, Inc. (GHDX) in Q2 2018, closing a stake of 65,000 shares — an estimated $2.03M sold.

Millrace Asset Group first reported a position in GHDX in Q1 2018 and held it in 1 quarter. The position peaked at $2.03M in Q1 2018. 166 funds tracked by Wall St. Rank hold GHDX as of Q2 2018.

  • Millrace Asset Group reported no remaining Genomic Health, Inc. position as of Q2 2018 after selling out during the quarter.
  • Millrace Asset Group sold 65,000 Genomic Health, Inc. shares in Q2 2018, an estimated $2.03M.
  • Millrace Asset Group first reported a position in Genomic Health, Inc. in Q1 2018 and held it in 1 quarter.
  • Millrace Asset Group's Genomic Health, Inc. position peaked at $2.03M in Q1 2018.
  • 166 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2018.

Based on Millrace Asset Group's 13F filing for Q2 2018, filed 14 Aug 2018.